Target intelligence / Profile preview

Undecaprenyl pyrophosphate phosphatase (UPPP) (UPPP)

Target
UPPP
Molecular classification
Enzyme, Phosphatase, Hydrolase
01

Overview

The undecaprenyl pyrophosphate (UPP) phosphatase system is a critical component of bacterial cell wall biosynthesis, responsible for recycling the essential C55-isoprenoid lipid carrier (UniProt P0A921). This system is primarily centered on the enzyme undecaprenyl pyrophosphate phosphatase (UPPP), also known as BacA or UppP, which dephosphorylates UPP to undecaprenyl phosphate (UP) (El Ghachi et al., 2004, J. Biol. Chem.). UP is required to transport peptidoglycan, teichoic acid, and O-antigen precursors from the cytoplasm across the cell membrane (Manat et al., 2014, Antibiotics). Since the total amount of undecaprenyl lipids in the cell is limited, the efficient recycling of UPP back to UP is necessary to maintain cell wall integrity and bacterial viability. Inhibition of this recycling process leads to the accumulation of UPP and a deficiency of UP, effectively halting the assembly of the peptidoglycan layer and leading to cell lysis. The antibiotic bacitracin is the most prominent drug targeting this system; it forms a complex with UPP in the presence of divalent metal ions, thereby preventing the phosphatase from acting on its substrate (Stone and Strominger, 1971, PNAS). This target is highly effective against Gram-positive bacteria, although the systemic use of drugs like bacitracin is limited by potential nephrotoxicity (PubChem CID 439542).

Other names
BacAUppPC55-isoprenyl pyrophosphate phosphataseBactoprenyl-diphosphataseUndecaprenyl-diphosphatase
02

Mechanism of action

Inhibition of undecaprenyl pyrophosphate dephosphorylation by sequestering the substrate (UPP) or inhibiting the phosphatase enzyme (UPPP), preventing the recycling of the C55-lipid carrier required for cell wall synthesis.

03

Biological functions

Cell wall biosynthesisPeptidoglycan metabolic processLipid carrier recyclingIsoprenoid metabolism
04

Disease associations

Infection
05

Safety considerations

NephrotoxicityTopical administration restrictionAntibiotic resistance (via BacA overexpression)
06

Interacting drugs

Bacitracin

Beyond the preview

Go deeper on Undecaprenyl pyrophosphate phosphatase (UPPP) (UPPP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl pyrophosphate phosphatase (UPPP) (UPPP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call